经皮胫神经刺激治疗安全网医院男女膀胱过度活动症的疗效
本研究回顾性分析2015年5月至2019年1月在一所大型城市安全网医院接受经皮胫神经刺激(PTNS)治疗的50例膀胱过度活动症患者,平均年龄59±12岁,52%为男性,80%为黑人。患者平均完成10.7±2.7次周治疗,70%完成全部12次,86%报告症状改善,所有症状指标均显著改善(p<0.001)。结论认为PTNS在传统上服务不足的人群中具有良好疗效和依从性。
要点
- PTNS在安全网医院OAB患者中显示良好疗效,86%报告症状改善。
- 平均完成10.7±2.7次周治疗,70%完成全部12次。
- 所有症状指标显著改善(p<0.001),包括日间尿频、夜尿、尿急和尿失禁。
核心结论
- PTNS在传统上服务不足的患者群体中具有良好疗效和依从性,可作为管理OAB症状的可行方法。
研究设计与样本
- 回顾性队列研究,纳入2015年5月至2019年1月在Grady Memorial医院接受PTNS的连续患者50例,平均年龄59±12岁,80%黑人,52%男性,34%无保险,54%政府保险。
主要发现
- 患者平均完成10.7±2.7次周治疗,70%完成全部12次,完成12次者中77%继续维持治疗。
- 治疗后平均日间排尿次数从11.0降至6.6次/天(-24.5%),夜尿从4.8降至2.5次/晚(-47.1%),尿急评分从3.4降至1.9(-42.1%),尿失禁从1.6降至0.4次/天(-79.6%),各p<0.001。
- 43例(86%)报告症状改善。
关键数值与推荐
- 既往治疗:100%行为调整,86%抗胆碱能药,4%米拉贝隆。
临床怎么用
- 对于类似人口学特征(如安全网医院就诊、少数族裔、无保险或政府保险)的OAB患者,PTNS是可行的治疗选择。
局限性
- 回顾性研究,样本量较小(50例),单中心,缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated efficacy and compliance related to percutaneous tibial nerve stimulation in patients treated for overactive bladder at a large, urban safety net hospital. MATERIALS AND METHODS: Consecutive patients who underwent percutaneous tibial nerve stimulation at Grady Memorial Hospital from May 2015 through January 2019 were included in our cohort and records were reviewed retrospectively. Primary outcomes of interest included self-reported urinary symptoms and episodes of urinary incontinence. Our secondary outcome of interest was patient compliance, defined as completion of 12 or more treatment sessions. Descriptive analysis and paired t-tests were performed. RESULTS: Of the 50 patients with a mean ± SD age of 59 ± 12 years 80% were black, 52% were male, 34% were uninsured and 54% subscribed to government insurance. Prior treatment included behavioral modification in 100% of cases, anticholinergics in 86% and mirabegron in 4%. Patients completed a mean of 10.7 ± 2.7 of the 12 planned weekly percutaneous tibial nerve stimulation treatments. Of the patients 70% completed all 12 weekly treatments and 77% of those who completed 12 treatments continued to maintenance treatment. After percutaneous tibial nerve stimulation treatment average symptoms improved across all metrics, including mean daytime frequency (from 11.0 to 6.6 episodes per day or -24.5%), nighttime frequency (from 4.8 to 2.5 episodes per night or -47.1%), urgency score (from 3.4 to 1.9 or -42.1%) and incontinence (from 1.6 to 0.4 episodes per day or -79.6%) (each p <0.001). A total of 43 patients (86%) reported symptom improvement. CONCLUSIONS: Percutaneous tibial nerve stimulation had favorable efficacy and compliance in a traditionally underserved patient population. This should be considered as a feasible modality to manage overactive bladder symptoms in patients in a similar demographic.
引用
- Jiang JF, Leung AK, Pettitt-Schieber B, et al. Efficacy of Percutaneous Tibial Nerve Stimulation for Overactive Bladder in Women and Men at a Safety Net Hospital. J Urol. 2019. PMID: 31518202. doi:10.1097/JU.0000000000000539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。